menu
    • menu

    Company profile for Bionxt Solutions

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bionxt is striving to have a positive impact on global health We are creating potentially life-changing solutions through research, development and collaboration. Bionxt Solutions works with promising disrupters in the pharmaceutical industry; accelerates research and technology development; and commercializes products with an entrepreneurial approach and a commitment to efficiency, effectiveness and accessibility.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bionxt SolutionsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Suite 1500 – 1055 W Georgia Street Vancouver, BC V6E 4N7 C
    Telephone
    Telephone
    +1-780-818-6422
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bionxt.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioNxt Targets Global Pill-Swallowing Issue with Rapid-Dissolving
    BioNxt Targets Global Pill-Swallowing Issue with Rapid-Dissolving

    17 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-17/over-40-of-adults-struggle-to-swallow-pills-bionxt-targets-a-global-adherence-problem-with-rapid

    PHARMIWEB
    17 Dec 2025
    Share Share
    BioNxt Enhances Cladribine Formulation For MS Patients
    BioNxt Enhances Cladribine Formulation For MS Patients

    09 Dec 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionxt-advances-%22melt-in-your-mouth%22-cladribine-formulation-to-improv-1115793

    ACCESSWIRE
    09 Dec 2025
    Share Share
    BioNxt to Acquire 100% IP and Codevelop Sublingual Formulation
    BioNxt to Acquire 100% IP and Codevelop Sublingual Formulation

    01 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-01/bionxt-signs-letter-agreement-to-acquire-100-interest-in-ip-and-to-codevelop-a-sublingual-drug-form

    PHARMIWEB
    01 Dec 2025
    Share Share
    Bionxt Secures Eurasian Patent For Sublingual MS Therapy
    Bionxt Secures Eurasian Patent For Sublingual MS Therapy

    24 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/bionxt-secures-eurasian-patent-for-breakthrough-sublingual-ms-therapy-18336

    INDPHARMAPOST
    24 Nov 2025
    Share Share
    Bionxt Secures Eurasian Patent For Sublingual Cladribine Platform
    Bionxt Secures Eurasian Patent For Sublingual Cladribine Platform

    20 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-20/bionxt-secures-final-patent-grant-from-the-eurasian-patent-organization-for-sublingual-cladribine-pl

    PHARMIWEB
    20 Nov 2025
    Share Share
    BioNxt Gets EPO Intention to Grant for Oral Cladribine Film
    BioNxt Gets EPO Intention to Grant for Oral Cladribine Film

    04 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-04/bionxt-reports-intention-to-grant-patent-notification-from-the-european-patent-office-for-its-oral

    PHARMIWEB
    04 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search